Navigation Links
ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
Date:8/23/2007

Protocols on ImmuneRegen's Homspera(TM) Submitted to RFI, 'Therapeutic

Countermeasures against CDC Category A and B Threat Agents'

SCOTTSDALE, Ariz., Aug. 23 /PRNewswire-FirstCall/ -- Research and development biotechnology company ImmuneRegen BioSciences, Inc. a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTC Bulletin Board: IRBO.OB), announced today that it has recently responded to a Request for Information (RFI) from the Defense Threat Reduction Agency (DTRA) of the Department of Defense for Therapeutic Countermeasures against CDC Category A and B Threat Agents. ImmuneRegen made its submission August 20, 2007 with information on its potential treatment, Homspera(TM).

ImmuneRegen filed a formal response to the RFI respective to its compound Homspera(TM), currently in development as a therapeutic and prophylactic countermeasure against multiple pathogens including multiple biological, chemical and radiological threats. For the purposes of this request, the RFI submission focuses primarily on anthrax countermeasures.

"We believe that Homspera is at the forefront of the development of Category A and B countermeasures," commented Michael Wilhelm, co-founder and CEO of ImmuneRegen. "Our studies have shown Homspera to be effective in protecting experimental animals against the lethal effects of ionizing radiation, infection with anthrax spores, infection with influenza virus, and to be an adjuvant in influenza vaccine studies. We believe Homspera's mode of action includes an immunostimulatory activity that results in enhanced host defenses against multiple pathogens."

Should this RFI lead to further studies, ImmuneRegen expects to partner with appropriate governmental agencies, such as USAMRIID (U.S. Army Medical Research Institute for Infectious Diseases) or AFIP (Armed Forces Institute of Pathology).

About Homspera(TM)

Homspera is a generic name used by the Company to describe the synthetic peptide Sar
'/>"/>

SOURCE ImmuneRegen BioSciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Third Wave responds to Digene patent lawsuit
2. Epic responds to critics of electronic record installation
3. Small Tree Communications awarded $2.85M defense contract
4. Research consortium aims to bring security and defense contracts to Wisconsin
5. MATC student team wins cyber defense contest
6. National Bio and Agro Defense fits Wisconsin
7. Chippewa Valley firms land more defense work
8. Wisconsins failure to attract federal defense dollars crimps tech economy
9. Defense contract helps Plexus gain record profits
10. Chippewa Valley to get $46 million in defense spending
11. Wisconsins untapped defense might: why saving military bases is just a start

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wswire/--BiotechfirmReplikinsLtd.,whichhasanalyzed...theprediction,outbreak,andprogressofthecurrentH1N1...thevirus.ThenewdatashowsthatthelethalityoftheH1N1(...)duringthevirus,scurrentoutbreakinthespringof2009t...heH1N1virus,infectivitycount,however,remainsincrea...
(Date:11/25/2009)...ewswire-Asia/--SinovacBiotechLtd.(SVA),aleadingde...xecuted,ajointventure(JV)agreementtoestablishSinov...).TheJVwillresearch,develop,produce,andcommerciali...ise,andexperienceindevelopingandcommercializingwor...rights,manufacturingfacilitiesand,establishedopera...
(Date:11/24/2009)...ewswire-FirstCall/--IES(Nasdaq: IESC ),aleadingnat...ndservicesforthecommercial,industrialandresidentia...ouphasbeenawardedacontractfromManhattanTorconJVtoi...b(BSL-4)replacementfacilityattheU.S.ArmyMedicalRes...DetrickinFrederick,Md. ,, ThenewUSAMRIIDreplace...
(Date:11/24/2009)...,Ontario,Nov.24/PRNewswire-FirstCall/--DowAgroScie...landSeeds,adivisionofThompsonsLimitedofBlenheim,On...AgroSciences,currentseedsbusinessasthecompanyantic...dDowAgroSciencesHerbicideTolerantTraitTechnologyin...rfuture. ,, "Thisacquisitionbringstogethertwost...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
... Multiporator / Electroporator 2510 , , ,... Transformation Protocol , Pr... , , , , , , , ,... Nocardia corallina, , ...am positive, , , Mo...
... Multiporator , , , , , , ...on Protocol , Protocol No. 4308 915.04..., , , , , , ,..., , , Cell type ,..., , Transformation with , ...
... Multiporator , , , , , , ... Protocol , Protocol No. 4308 915.036 ... , , , , , , ...rovascular endothelial cells from , r... , Transfection with , Plas...
Other Biology Technology:Nocardia corallina 2Neurospora crassa 2Primary cells, rat heart endothel 2
(Date:11/24/2009)... Springer and the American College of Medical Toxi...ate on the publication of the Journal of Medical ...T, beginning in March 2010. It was previously pub..., The Journal of Medical Toxicology , an interna...ancing the science and practice of medical toxicol...
(Date:11/24/2009)... This release is available in Spanish . , ...higher levels of inflammatory substances in the bl...ht; as shown by a research project of the Universi...o, a scientist at the School of Pharmacy. , The ... study in relation to the control of body weight a...
(Date:11/23/2009)..., A new study by the Wildlife Conservation Societ...arge swamp in the Republic of Congopart of the "mo...d last yearare becoming increasingly threatened by...udy recommends protection of the swamp forests adj...Reserve after recent surveys confirmed that high d...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting 13461 1WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting 13461 2Research breakthrough will lead to more accurate weather forecasts 13460 1Research breakthrough will lead to more accurate weather forecasts 13460 2Mental Activity Seems to Keep the Brain Vital 54005 1Mental Activity Seems to Keep the Brain Vital 54005 2
... cells with the capacity to build fat, according t...l Cell, a Cell Press publication. Although they ...es, transplants of the progenitor cells isolated f...al fat tissue in animals that are otherwise lackin...ses of obesity, a condition characterized by an in...
...gy have shaped not only how we find or share infor...ect just funded by the National Institutes of Heal... next level. , The University of Michigan will le...data needed to develop computer programs that more... data will be housed in a Web-based resource that ...
...m the Herman B Wells Center for Pediatric Research...focusing on a family of blood proteins that they ...f chemotherapy in children and adults. , Their f...geted therapies for leukemia, multiple myeloma and...ed by Kristin T. Chun, Ph.D., assistant professor ...
Other Biology News:Fat-regenerating 'stem cells' found in mice 2New data resource to advance computer-aided drug design 2On the trail of a targeted therapy for blood cancers 2
GIBCO Newborn Calf Serum from Invitrogen
...d efficient removal of short primers, dNTPs, enzym...products (Figure 1). The simple PureLink bind/wash...tions for fragments >100 bp or >300 bp* , can be p...format , takes ,Two proprietary buffers are supp...
...nute cloning and subsequent sequencing of PCR prod...rimer sites located as close as 33 base pairs from...e amount of vector DNA that needs to be read befor... available. The pCR4-TOPO vector provides 3-T over...
Zebrafish Vitellogenin ELISA System from GE Healthcare, formerly Amersham Biosciences
Biology Products: